Licensed vaccine
Flublok
FDA-licensed vaccine · Protein Sciences Corporation · STN 125285
Key facts
| Trade name | Flublok |
|---|---|
| Proper name | Influenza Vaccine (Trivalent) |
| Manufacturer | Protein Sciences Corporation |
| Submission tracking number (STN) | 125285 |
| Recent FDA documents | October 15, 2024 Approval Letter - Flublok, Package Insert - Flublok, July 1, 2024 Approval Letter - Flublok, June 30, 2023 Approval Letter - Flublok and Flublok Quadrivalent, Approval History, Letters, Reviews, and Related Documents - Flublok, July 7, 2017 Approval Letter - Flublok, Supporting Documents older than three years - Flublok |
| FDA page updated | Oct 16, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: